Loading...
Loading...

by Msn Laboratories Pvt Ltd· 1S
SKU: 962094
You save ₹3168 on this order
Inclusive of all taxes
LUPROCAN 22.5 INJECTION contains Leuprolide which belongs to the group of
medicines called Gonadotropin Releasing Hormone (GnRH) Agonist. It is used for
palliative management (relieving symptoms and minimising the associated
suffering) of advanced prostatic cancer. Advanced prostatic cancer is a cancer
(abnormal cell multiplication and differentiation) that originates in the
prostate gland and spreads to the other parts of the body. It is characterized
by the symptoms such as painful urination, decreased urine pressure, blood in
the semen, bone pain, leg swelling, and weakness.
Do not receive LUPROCAN 22.5 INJECTION if you are allergic to Leuprolide, GnRH,
GnRH agonist analogs. Before receiving the medicine, inform your doctor if you
have liver impairment, kidney impairment, congenital long QT syndrome,
congestive heart failure, frequent electrolyte abnormalities, metastatic
vertebral lesions, urinary tract obstruction, or diabetes. Before receiving this
medicine, inform your doctor if you have a history of seizures, epilepsy,
cerebrovascular disorders, or central nervous system anomalies/tumours. LUPROCAN
22.5 INJECTION is not recommended for use in pregnant women, breastfeeding
women, and children.
It should be used with caution in elderly patients (aged above 65 years).
Consult your doctor before receiving. The most common side effects associated
with the use of LUPROCAN 22.5 INJECTION are general pain, reactions at the site
of injection, hot flashes/sweating, gastrointestinal disorders, joint disorders,
shrinking of testes, urinary disorders, infections in upper respiratory tract,
and fatigue. Consult your doctor if any of these side effects worsens.
LUPROCAN 22.5 INJECTION contains Leuprolide which works by blocking the
secretion of gonadotropin releasing hormone (GnRH) following an initial
stimulation, resulting in suppression of ovarian and testicular steroidogenesis
(process of synthesis of steroid hormones), thereby relieving the symptoms
associated with increased testosterone levels in advanced prostatic cancer.
LUPROCAN 22.5 INJECTION will be administered to you only by a doctor or a nurse
intramuscularly (into the muscle) or subcutaneously (under the skin). Your
doctor will administer the correct dose and duration for you depending upon your
age, body weight and disease condition.
Stop receiving LUPROCAN 22.5 INJECTION and contact your doctor if you experience
any of the following side effects:
!### Constipation
Try to eat more high-fibre foods such as fresh fruit, vegetables, cereals, and
drink plenty of water. Try doing exercise regularly (going for a daily walk or
run). If this does not help, inform your doctor for receiving alternate
managements for constipation.
!### Dizziness Or Drowsiness
Lie down until the dizziness passes and get up slowly. Do not bend down
suddenly. Get a lot of rest. Walk slowly and carefully. Take plenty of fluids.
Avoid drinking coffee, alcohol, or smoking. Consult your doctor if the condition
persists for long or gets worsens.
Take rest and plenty of water. Avoid taking alcohol and skipping meals. Do not
strain your eyes by watching the screen for a long time. Consult your doctor if
the condition persists for long or gets worsens.
ContraindicatedLUPROCAN 22.5 INJECTION is not recommended for use during pregnancy. Consult
your doctor before receiving the medicine.
!### Breastfeeding
ContraindicatedLUPROCAN 22.5 INJECTION is not recommended for use in breastfeeding women as it
can pass through milk. Consult your doctor before receiving the medicine.
!### Driving and Using Machines
Use with CautionDo not receive LUPROCAN 22.5 INJECTION if you are allergic to Leuprolide, GnRH,
GnRH agonist analogs, or to any of the other ingredients of this medicine.
!### Kidney
Use with CautionLUPROCAN 22.5 INJECTION should be used with caution in patients with renal
impairment. Consult your doctor before receiving the medicine.
!### Liver
Use with CautionLUPROCAN 22.5 INJECTION should be used with caution in patients with hepatic
impairment. Consult your doctor before receiving the medicine.
!### Heart Disease
Monitoring requiredLUPROCAN 22.5 INJECTION should be used with caution in patients with congenital
long QT syndrome and congestive heart failure only if clearly necessary. Consult
your doctor before receiving.
!### Use In Pediatrics
ContraindicatedLUPROCAN 22.5 INJECTION is not recommended for use in children. Consult your
doctor before receiving.
!### Use In Geriatrics
Use with CautionLUPROCAN 22.5 INJECTION should be used with caution in elderly patients (above
65 years). Consult your doctor before receiving the medicine.
Before receiving LUPROCAN 22.5 INJECTION, inform your doctor if you:
A. Drug-Drug Interactions:
Before receiving LUPROCAN 22.5 INJECTION, inform your doctor, if you are taking
any of the following medicine:
Overdosage:
LUPROCAN 22.5 INJECTION will be given to you only by a doctor or nurse in a
hospital, and so it is unlikely to receive an overdose. If you or anyone else
accidentally receives too much of this medicine, consult your doctor immediately
or visit the nearby hospital. Symptoms of overdose are shortness of breath,
decreased activity, and increased scratching.
| Drug | : | Leuprolide |
| Pharmacological Category | : | Gonadotropin Releasing Hormone (GnRH) Agonist |
| Therapeutic Indication | : | Palliative management for advanced prostatic cancer |
| Dosage Forms | : | Injection, Injection depot |
A: LUPROCAN 22.5 INJECTION for palliative management (relieving symptoms and
minimize the associated suffering) of advanced prostatic cancer. Consult your
doctor before receiving.
A: The most common side effects associated with the use of LUPROCAN 22.5
INJECTION are general pain, reactions at the site of injection, hot
flashes/sweating, gastrointestinal disorders, joint disorders, shrinking of
testes, urinary disorders, infections in the upper respiratory tract, and
fatigue. Consult your doctor if any of these symptoms worsens.
A: Do not receive LUPROCAN 22.5 INJECTION if you are allergic to leuprolide,
GnRH, GnRH agonist analogs. It is not recommended for use in pregnant women,
breastfeeding women, and children. Consult your doctor before receiving.
A: LUPROCAN 22.5 INJECTION is not recommended for use in children because the
safety and effectiveness of this medicine have not been established in this
population. Consult your doctor before receiving.
A: LUPROCAN 22.5 INJECTION is not recommended for use during pregnancy as it may
increase the risk for pregnancy loss. It is also not recommended for use in
breastfeeding women as it can pass through milk. Consult your doctor before
receiving.
A: LUPROCAN 22.5 INJECTION will be given to you only by a doctor or nurse in a
hospital, and so it is unlikely to receive an overdose. If you or anyone else
accidentally receives too much of this medicine, consult your doctor immediately
or visit the nearby hospital. Symptoms of overdose are shortness of breath,
decreased activity, and increased scratching.
A: LUPROCAN 22.5 INJECTION should be used with caution in patients with
congenital long QT syndrome and congestive heart failure only if clearly
necessary. Consult your doctor before receiving.
LUPROCAN 22.5 INJECTION contains Leuprolide which belongs to the group of
medicines called Gonadotropin Releasing Hormone (GnRH) Agonist. It is used for
palliative management (relieving symptoms and minimising the associated
suffering) of advanced prostatic cancer. Advanced prostatic cancer is a cancer
(abnormal cell multiplication and differentiation) that originates in the
prostate gland and spreads to the other parts of the body. It is characterized
by the symptoms such as painful urination, decreased urine pressure, blood in
the semen, bone pain, leg swelling, and weakness.
Do not receive LUPROCAN 22.5 INJECTION if you are allergic to Leuprolide, GnRH,
GnRH agonist analogs. Before receiving the medicine, inform your doctor if you
have liver impairment, kidney impairment, congenital long QT syndrome,
congestive heart failure, frequent electrolyte abnormalities, metastatic
vertebral lesions, urinary tract obstruction, or diabetes. Before receiving this
medicine, inform your doctor if you have a history of seizures, epilepsy,
cerebrovascular disorders, or central nervous system anomalies/tumours. LUPROCAN
22.5 INJECTION is not recommended for use in pregnant women, breastfeeding
women, and children.
It should be used with caution in elderly patients (aged above 65 years).
Consult your doctor before receiving. The most common side effects associated
with the use of LUPROCAN 22.5 INJECTION are general pain, reactions at the site
of injection, hot flashes/sweating, gastrointestinal disorders, joint disorders,
shrinking of testes, urinary disorders, infections in upper respiratory tract,
and fatigue. Consult your doctor if any of these side effects worsens.
LUPROCAN 22.5 INJECTION contains Leuprolide which works by blocking the
secretion of gonadotropin releasing hormone (GnRH) following an initial
stimulation, resulting in suppression of ovarian and testicular steroidogenesis
(process of synthesis of steroid hormones), thereby relieving the symptoms
associated with increased testosterone levels in advanced prostatic cancer.
LUPROCAN 22.5 INJECTION will be administered to you only by a doctor or a nurse
intramuscularly (into the muscle) or subcutaneously (under the skin). Your
doctor will administer the correct dose and duration for you depending upon your
age, body weight and disease condition.
Stop receiving LUPROCAN 22.5 INJECTION and contact your doctor if you experience
any of the following side effects:
!### Constipation
Try to eat more high-fibre foods such as fresh fruit, vegetables, cereals, and
drink plenty of water. Try doing exercise regularly (going for a daily walk or
run). If this does not help, inform your doctor for receiving alternate
managements for constipation.
!### Dizziness Or Drowsiness
Lie down until the dizziness passes and get up slowly. Do not bend down
suddenly. Get a lot of rest. Walk slowly and carefully. Take plenty of fluids.
Avoid drinking coffee, alcohol, or smoking. Consult your doctor if the condition
persists for long or gets worsens.
Take rest and plenty of water. Avoid taking alcohol and skipping meals. Do not
strain your eyes by watching the screen for a long time. Consult your doctor if
the condition persists for long or gets worsens.
ContraindicatedLUPROCAN 22.5 INJECTION is not recommended for use during pregnancy. Consult
your doctor before receiving the medicine.
!### Breastfeeding
ContraindicatedLUPROCAN 22.5 INJECTION is not recommended for use in breastfeeding women as it
can pass through milk. Consult your doctor before receiving the medicine.
!### Driving and Using Machines
Use with CautionDo not receive LUPROCAN 22.5 INJECTION if you are allergic to Leuprolide, GnRH,
GnRH agonist analogs, or to any of the other ingredients of this medicine.
!### Kidney
Use with CautionLUPROCAN 22.5 INJECTION should be used with caution in patients with renal
impairment. Consult your doctor before receiving the medicine.
!### Liver
Use with CautionLUPROCAN 22.5 INJECTION should be used with caution in patients with hepatic
impairment. Consult your doctor before receiving the medicine.
!### Heart Disease
Monitoring requiredLUPROCAN 22.5 INJECTION should be used with caution in patients with congenital
long QT syndrome and congestive heart failure only if clearly necessary. Consult
your doctor before receiving.
!### Use In Pediatrics
ContraindicatedLUPROCAN 22.5 INJECTION is not recommended for use in children. Consult your
doctor before receiving.
!### Use In Geriatrics
Use with CautionLUPROCAN 22.5 INJECTION should be used with caution in elderly patients (above
65 years). Consult your doctor before receiving the medicine.
Before receiving LUPROCAN 22.5 INJECTION, inform your doctor if you:
A. Drug-Drug Interactions:
Before receiving LUPROCAN 22.5 INJECTION, inform your doctor, if you are taking
any of the following medicine:
Overdosage:
LUPROCAN 22.5 INJECTION will be given to you only by a doctor or nurse in a
hospital, and so it is unlikely to receive an overdose. If you or anyone else
accidentally receives too much of this medicine, consult your doctor immediately
or visit the nearby hospital. Symptoms of overdose are shortness of breath,
decreased activity, and increased scratching.
| Drug | : | Leuprolide |
| Pharmacological Category | : | Gonadotropin Releasing Hormone (GnRH) Agonist |
| Therapeutic Indication | : | Palliative management for advanced prostatic cancer |
| Dosage Forms | : | Injection, Injection depot |
A: LUPROCAN 22.5 INJECTION for palliative management (relieving symptoms and
minimize the associated suffering) of advanced prostatic cancer. Consult your
doctor before receiving.
A: The most common side effects associated with the use of LUPROCAN 22.5
INJECTION are general pain, reactions at the site of injection, hot
flashes/sweating, gastrointestinal disorders, joint disorders, shrinking of
testes, urinary disorders, infections in the upper respiratory tract, and
fatigue. Consult your doctor if any of these symptoms worsens.
A: Do not receive LUPROCAN 22.5 INJECTION if you are allergic to leuprolide,
GnRH, GnRH agonist analogs. It is not recommended for use in pregnant women,
breastfeeding women, and children. Consult your doctor before receiving.
A: LUPROCAN 22.5 INJECTION is not recommended for use in children because the
safety and effectiveness of this medicine have not been established in this
population. Consult your doctor before receiving.
A: LUPROCAN 22.5 INJECTION is not recommended for use during pregnancy as it may
increase the risk for pregnancy loss. It is also not recommended for use in
breastfeeding women as it can pass through milk. Consult your doctor before
receiving.
A: LUPROCAN 22.5 INJECTION will be given to you only by a doctor or nurse in a
hospital, and so it is unlikely to receive an overdose. If you or anyone else
accidentally receives too much of this medicine, consult your doctor immediately
or visit the nearby hospital. Symptoms of overdose are shortness of breath,
decreased activity, and increased scratching.
A: LUPROCAN 22.5 INJECTION should be used with caution in patients with
congenital long QT syndrome and congestive heart failure only if clearly
necessary. Consult your doctor before receiving.